*BEST OF DTB #152* The Catholic Defender: Chemical Castration of Women

Posted by John Benko - March 6th, 2012

The past few weeks there has been much talk about the Obama Administration’s war on the Catholic Faith.

The Progressives want to make Birth Control part of health care making it a mandate forcing the Church to bend the knee to Obama.

From what I can see, there has been little to say about the health risk associated to oral contraception.

I have learned that women who are “ER” (Estrogen) positive are at a higher risk of breast cancer using the Pill, which is the highest rate of diagnosis.

About 60% of all breast cancer is due to being Estrogen Positive.

About.com explains breast cancer this way “A score of Estrogen Receptor positive (ER+) means that estrogen is causing your tumor to grow, and that the cancer should respond well to hormone suppression treatments. If the score is Estrogen Receptor negative (ER-), then your tumor is not driven by estrogen, and your results will need to be evaluated along with other tests, such as your HER2 status, to determine the most effective treatment. If you get a Progesterone Receptor positive (PgR+ or PR+) score, the cancer should respond well to hormone suppression treatments. If the score is Progesterone Receptor negative (PgR- or PR-), then your tumor is not driven by progesterone, and another test is needed, for your HER2 status, to determine the most effective treatment. HER2 positive breast cancer responds well to Herceptin treatment.”

The most common birth control pills currently handed out by pharmacies combine estrogen and progestin with the intent to circumvent fertility in women through the prevention of ovulation. With a doctors prescription, people can go to any pharmacy and compare various brand names. They commonly contain the same estrogen “ethinyl estradiol” depending on the strength, and can have certain side effects.

The following is taken from Breastcancer.org:

About 1 in 8 U.S. women (just under 12%) will develop invasive breast cancer over the course of her lifetime.

In 2011, an estimated 230,480 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S., along with 57,650 new cases of non-invasive (in situ) breast cancer.

About 2,140 new cases of invasive breast cancer were expected to be diagnosed in men in 2011. A man’s lifetime risk of breast cancer is about 1 in 1,000.

From 1999 to 2005, breast cancer incidence rates in the U.S. decreased by about 2% per year. The decrease was seen only in women aged 50 and older. One theory is that this decrease was partially due to the reduced use of hormone replacement therapy (HRT) by women after the results of a large study called the Women’s Health Initiative were published in 2002. These results suggested a connection between HRT and increased breast cancer risk.

About 39,520 women in the U.S. were expected to die in 2011 from breast cancer, though death rates have been decreasing since 1990 — especially in women under 50. These decreases are thought to be the result of treatment advances, earlier detection through screening, and increased awareness. (Sandra Fluke is a Georgetown Law student seeking to have the public pay for her contraception. It is interesting that the media turns a blind eye to the health risk posed by ABC).

For women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer.

Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women. Just under 30% of cancers in women are breast cancers.

White women are slightly more likely to develop breast cancer than African-American women. However, in women under 45, breast cancer is more common in African-American women than white women. Overall, African-American women are more llkely to die of breast cancer. Asian, Hispanic, and Native-American women have a lower risk of developing and dying from breast cancer.

In 2011, there were more than 2.6 million breast cancer survivors in the US.

A woman’s risk of breast cancer approximately doubles if she has a first-degree relative (mother, sister, daughter) who has been diagnosed with breast cancer. About 15% of women who get breast cancer have a family member diagnosed with it.

About 5-10% of breast cancers can be linked to gene mutations (abnormal changes) inherited from one’s mother or father. Mutations of the BRCA1 and BRCA2 genes are the most common. Women with these mutations have up to an 80% risk of developing breast cancer during their lifetime, and they are more likely to be diagnosed at a younger age (before menopause). An increased ovarian cancer risk is also associated with these genetic mutations.

In men, about 1 in 10 breast cancers are believed to be due to BRCA2 mutations, and even fewer cases to BRCA1 mutations.

About 85% of breast cancers occur in women who have no family history of breast cancer. These occur due to genetic mutations that happen as a result of the aging process and life in general, rather than inherited mutations.
The most significant risk factors for breast cancer are gender (being a woman) and age (growing older).


Home page
DTB facebook Page
You Tube
Blog Talk Radio Show